These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2576360

  • 1. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
    Neugebauer G, Raedsch R, Stiehl A, Kaufmann B, Besenfelder E, Neubert P, Walter-Sack I.
    Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
    Neugebauer G, Wittenbrink-Dix AM, Woelke-Seidl E, Kaufmann B, Ponton T, Dahmen W, Mosberg H, Nieder N, Besenfelder E.
    Arzneimittelforschung; 1989 Oct; 39(10A):1336-9. PubMed ID: 2576358
    [Abstract] [Full Text] [Related]

  • 3. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
    Wittenbrink-Dix AM, Neugebauer G, Fuhr U, Neubert P, Besenfelder E, Woelke-Seidl E, Harder S, Staib AH.
    Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
    Schaumann W, Besenfelder E, Boehm E, Neubert P, Roesch A, Sterz H.
    Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356
    [Abstract] [Full Text] [Related]

  • 5. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
    Slapke J, Müller S, Boerner D.
    Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
    [Abstract] [Full Text] [Related]

  • 6. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
    Franke W, Messinger D.
    Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
    [Abstract] [Full Text] [Related]

  • 7. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients.
    Boerner D, Metz K, Eberhardt R.
    Arzneimittelforschung; 1989 Oct; 39(10A):1363-7. PubMed ID: 2576365
    [Abstract] [Full Text] [Related]

  • 9. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep.
    Abraham WM.
    Arzneimittelforschung; 1989 Oct; 39(10A):1328-31. PubMed ID: 2576357
    [Abstract] [Full Text] [Related]

  • 10. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
    Zimmermann I, Roesch A, Ulmer WT.
    Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [Abstract] [Full Text] [Related]

  • 12. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis.
    Boerner D, Metz K, Eberhardt R, Schürmann W.
    Arzneimittelforschung; 1989 Oct; 39(10A):1356-9. PubMed ID: 2576363
    [Abstract] [Full Text] [Related]

  • 13. Double-blind study on the influence of picumast dihydrochloride on safety-related performance.
    Herberg KW.
    Arzneimittelforschung; 1989 Oct; 39(10A):1348-51. PubMed ID: 2576361
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
    Besenfelder E, Neubert P, Roesch A, Schaumann W, Wilhelms OH.
    Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
    [Abstract] [Full Text] [Related]

  • 15. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A, Schaumann W, Wilhelms OH.
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [Abstract] [Full Text] [Related]

  • 16. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ, Lee WI, Shim HJ, Lee SD, Kim WB, Yang J, Lee MG.
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [Abstract] [Full Text] [Related]

  • 17. Acceptability, safety and efficacy of picumast dihydrochloride on long-term use in patients with perennial bronchial asthma.
    Boerner D, Metz K, Eberhardt R.
    Arzneimittelforschung; 1989 Oct; 39(10A):1372-4. PubMed ID: 2576367
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J, Dulery BD, Hornsperger JM, Di Francesco GF, Keshary P, Haegele KD.
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [Abstract] [Full Text] [Related]

  • 19. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
    Franke W, Bachert C, Messinger D.
    Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
    [Abstract] [Full Text] [Related]

  • 20. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I, de Vries JX, von Bubnoff A, Pfleilschifter V, Raedsch R.
    Eur J Med Res; 1995 Oct 16; 1(1):16-20. PubMed ID: 9392688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.